Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome.
Joelle KeferKarlien CarbonezSophie PierardFrançois-Pierre MouthuyAndré PeetersCedric HermansCatherine Marie LambertChristophe DeMeesterThierry SluysmansAgnes A PasquetPublished in: Journal of interventional cardiology (2022)
Short-term (6 months) ATT after PFO closure did not impair the clinical outcome, with a preserved low rate of recurrent stroke (0.3% patient-year) and device thrombosis (0.2% patient-year) at 10-year follow-up.